TAYLOR BIEBERLE: Open Payments
NPI 1497278972 · HOISINGTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$132 in 7 payments from 7 companies in 2025. Trend: 2023 $182 · 2024 $199 · 2025 $132
Food & beverage: $132
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: VRAYLAR, GEMTESA, STRENSIQ, MOUNJARO, AIRSUPRA, BEXSERO, NURTEC ODT.
Industry payments across KS — which companies pay providers there.
